"10.1371_journal.pone.0134839","plos one","2015-07-31T00:00:00Z","Wolf Peter Hofmann; Stefan Mauss; Thomas Lutz; Andreas Schober; Klaus Böker; Gero Moog; Axel Baumgarten; Heike Pfeiffer-Vornkahl; Ulrich Alshuth; Dietrich Hüppe; Heiner Wedemeyer; Michael P Manns; Eckart Schott","Practice of Gastroenterology, Berlin, Germany; Center for HIV and Hepatogastroenterology, Düsseldorf, Germany; Infektiologikum, Frankfurt, Germany; Practice of Hepatology, Göttingen, Germany; Practice of Hepatology, Hannover, Germany; Practice of Gastroenterology, Kassel, Germany; Center of Infectious Diseases, Berlin, Germany; Institute for Clinical Research and Statistics, Offenbach, Germany; Virology, Roche Pharma AG, Grenzach-Wyhlen, Germany; Center of Gastroenterology, Herne, Germany; Department of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany; Dept. of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany","Conceived and designed the experiments: WPH SM TL AS KB GM AB HPV DH HW MPM ES UA. Performed the experiments: WPH SM TL AS KB GM AB HPV DH HW MPM ES. Analyzed the data: WPH SM UA DH. Wrote the paper: WPH SM UA DH.","The authors have read the journal's policy and the authors of this manuscript have the following competing interests: WPH has participated in speakers bureau for Gilead, and has received speakers honoraria from BMS, MSD, Roche, Janssen, Boehringer Ingelheim, Gilead. SM has participated in Advisory boards for Abbvie, BI, BMS, Gilead, Janssen, and Roche and speakers bureau for Abbvie, BI, BMS, Gilead, Janssen, MSD, and Roche, and has received travel support from Abbvie, BI, BMS, Gilead, Janssen, MSD and Roche. TL has participated in Advisory boards for Abbvie, MSD, Janssen, BI and Gilead and speakers bureau for Abbvie, Roche, Gilead, BMS, Janssen, MSD and BI, and has received travel support from BMS and Gilead. KB has received speakers fees and participated in advisory meetings for Janssen, Roche, MSD, Gilead, BMS and Abbvie. GM has acted as a consultant for Roche, MSD, Janssen-Cilag and AbbVie. AB has participated in Advisory boards for Abbvie, BI, BMS, Gilead, Janssen and Roche, and speakers bureau for Abbvie, BI, BMS, Gilead, Janssen, MSD, Roche and ViiV, and has received travel support from Abbvie,BMS and Gilead. HP-V is an employee of CRO factum GmbH. UA is an employee of Roche AG. HW has received clinical research grants from the following companies: Abbott, Bristol Myers Squibb, Gilead, Merck, Novartis, Roche, Roche Diagnostics, Siemens; has received consultancy fees from Abbott, Abvie, Biolex, Bristol Myers Squibb, Boehringer Ingelheim, Gilead, ITS, JJ/Janssen-Cilag, Medgenics, Merck/Schering-Plough, Novartis, Roche, Roche Diagnostics, Siemens, Transgene, ViiV; has been a scientific advisor or consultant for Abbott, Abvie, Biolex, Bristol Myers Squibb, Boehringer Ingelheim, Gilead, ITS, JJ/Janssen-Cilag, Medgenics, Merck/Schering-Plough, Novartis, Roche, Roche Diagnostics, Siemens, Transgene; has received payment for development of educational presentations and speaker fees from Abbott, Bristol Myers Squibb, Gilead, ITS, JJ/Janssen-Cilag, Merck/Schering- Plough, Novartis, Roche; and has received payment for lectures including service on speakers bureaus for Abbott, Bristol Myers Squibb, Gilead, ITS, JJ/Janssen-Cilag, Merck/Schering-Plough, Novartis and Roche. MPM has participated in speaker bureau for Roche, Bristol Myers Squibb, GlaxoSmithKline, Gilead, Merck, and Janssen, has acted as a consultant for Roche, Bristol Myers Squibb, Gilead, Boehringer Ingelheim, Novartis, Tibotec, Vertex, Glaxo Smith Kline, Merck, Janssen, and has received grant / research support from Roche, Gilead, Novartis, Boehringer Ingelheim, BMS, Merck, and Janssen. ES has received fees for consultancy and speaking from Roche, MSD, Janssen, Abbvie, Gilead, BMS and BI, and travel support from Roche, Gilead, Abbvie, BMS, MSD. AS has no conflict of interest to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","07","Wolf Peter Hofmann","WPH",13,TRUE,13,12,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
